Dynamics of the lung microbiome in intensive care patients with chronic obstructive pulmonary disease and community-acquired pneumonia

被引:0
|
作者
Wei-Chang Huang
Ming-Feng Wu
Chen-Cheng Huang
Sin-Yin Liu
Hui-Chen Chen
Yih-Yuan Chen
Jeng-Yuan Hsu
Chieh-Chen Huang
机构
[1] National Chung Hsing University,Department of Life Sciences
[2] Taichung Veterans General Hospital,Division of Chest Medicine, Department of Internal Medicine
[3] Jen-Teh Junior College of Medicine,Department of Medical Technology
[4] Nursing and Management,Department of Industrial Engineering and Enterprise Information
[5] Tunghai University,Department of Medical Laboratory Science and Biotechnology
[6] Central Taiwan University of Science and Technology,Division of Chest Medicine, Department of Internal Medicine
[7] Taichung Hospital,Department of Biochemical Science and Technology
[8] Ministry of Health and Welfare,Division of Clinical Research, Department of Medical Research
[9] National Chiayi University,School of Medicine
[10] Taichung Veterans General Hospital,School of Physical Therapy
[11] China Medical University,undefined
[12] Chung-Shan Medical University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Little is known about the composition and clinical implications of lung microbiome in patients with chronic obstructive pulmonary disease (COPD) and community-acquired pneumonia requiring invasive mechanical ventilation and intensive care unit admission. Therefore, this study aimed to explore the longitudinal changes in microbial airway composition and its variations between COPD patients with different weaning outcomes. Fifty-one endotracheal aspirate samples from 21 participants and 5 saline samples were collected as the patient and control group, respectively. Sequence analysis revealed significant increases and upward trends in the relative abundance of the Acinetobacter genus and Acinetobacter baumannii complex species in paired comparisons of sampling points and over time, respectively, in patients with failed weaning (p for trend = 0.012 and 0.012, respectively) but not in those with successful weaning (p for trend = 0.335 and 0.426, respectively). Furthermore, significant changes in the composition of the bacterial community were observed in paired comparisons of sampling points in patients with failed weaning compared with those with successful weaning. The alpha diversity did not differ between the patients with different weaning outcomes. These results further the understanding of longitudinal airway microbiome structure analysis and its clinical implications when managing critically ill patients with and without COPD.
引用
收藏
相关论文
共 50 条
  • [41] Is chronic obstructive pulmonary disease a risk factor for death in patients with community acquired pneumonia?
    Bonnesen, Barbara
    Egelund, Gertrud Baunbaek
    Jensen, Andreas Vestergaard
    Andersen, Stine
    Petersen, Pelle Trier
    Rohde, Gernot
    Ravn, Pernille
    INFECTIOUS DISEASES, 2019, 51 (05) : 340 - 347
  • [42] Severe community-acquired pneumonia in the intensive care unit
    C Costa
    I Gouveia
    P Cunha
    R Milheiro
    A Bártolo
    C Gonçalves
    A Carvalho
    T Cardoso
    S Martins
    J Magalhaes
    Critical Care, 9 (Suppl 1):
  • [43] Intensive Care Unit Admission With Community-Acquired Pneumonia
    Vohra, Adam S.
    Tak, Hyo Jung
    Shah, Maulin B.
    Meltzer, David O.
    Ruhnke, Gregory W.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 350 (05): : 380 - 386
  • [44] COMMUNITY-ACQUIRED PNEUMONIA IN THE INTENSIVE-CARE UNIT
    LEEPER, KV
    TORRES, A
    CLINICS IN CHEST MEDICINE, 1995, 16 (01) : 155 - 171
  • [45] PIRO score for community-acquired pneumonia: A new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia
    Rello, Jordi
    Rodriguez, Alejandro
    Lisboa, Thiago
    Gallego, Miguel
    Lujan, Manel
    Wunderink, Richard
    CRITICAL CARE MEDICINE, 2009, 37 (02) : 456 - 462
  • [46] Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients
    Ao, Zhi
    Xu, Huan
    Li, Mengqi
    Liu, Huifang
    Deng, Min
    Liu, Yuliang
    BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [47] The impact of glycemic variability on length of stay and mortality in diabetic patients admitted with community-acquired pneumonia or chronic obstructive pulmonary disease
    Ferreira, L.
    Moniz, A. C.
    Carneiro, A. S.
    Miranda, A. S.
    Fangueiro, C.
    Fernandes, D.
    Silva, I
    Palhinhas, I
    Lemos, J.
    Antunes, J.
    Leal, M.
    Sampaio, N.
    Faria, S.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 149 - 153
  • [48] Community-acquired pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids or other bronchodilators. Study PNEUMOCORT
    Morros, Rosa
    Vedia, Cristina
    Giner-Soriano, Maria
    Casellas, Aina
    Amado, Ester
    Miguel Baena, Jose
    Almeda, Jesus
    Rodriguez, Teresa
    Plana-Ripoll, Oleguer
    Pera, Helena
    Rosell, Magdalena
    Elorza, Jose M.
    Toran, Pere
    ATENCION PRIMARIA, 2019, 51 (06): : 333 - 340
  • [49] Optimizing discharge antimicrobial therapy: Evaluation of a transitions of care process and electronic scoring system for patients with community-acquired pneumonia or chronic obstructive pulmonary disease
    Belza-Mai, Ana Christine
    Efta, Jessica
    Kenney, Rachel
    Macdonald, Nancy
    Stine, John
    Mccollom, Robert
    Ratusznik, Martin
    Patel, Nisha
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (24) : 1237 - 1244
  • [50] Prognosis of severe community-acquired pneumonia in alcoholic patients hospitalised in intensive care
    Cuny, J
    Chagnon, JL
    Lambiotte, F
    PRESSE MEDICALE, 2003, 32 (25): : 1162 - 1164